DOI QR코드

DOI QR Code

The Korean guideline for lung cancer screening

폐암 검진 권고안

  • Jang, Seung Hun (Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University College of Medicine) ;
  • Sheen, Seungsoo (Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine) ;
  • Kim, Hyae Young (Department of Radiology, National Cancer Center) ;
  • Yim, Hyeon Woo (Department of Preventive Medicine, The Catholic University of Korea College of Medicine) ;
  • Park, Bo Young (Graduate School of Cancer Science and Policy, National Cancer Center) ;
  • Kim, Jae Woo (National Cancer Control Institute, National Cancer Center) ;
  • Park, In Kyu (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Young Whan (Division of Pulmonary and Critical Care Medicine, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Lee, Kye Young (Department of Internal Medicine, Konkuk University School of Medicine) ;
  • Lee, Kyung Soo (Department of Radiology, Sungkyunkwan University School of Medicine) ;
  • Lee, Jong Mog (Department of Thoracic and Cardiovascular Surgery, National Cancer Center) ;
  • Hwangbo, Bin (Department of Pulmonology, National Cancer Center) ;
  • Paik, Sang Hyun (Department of Radiology, Soon Chun Hyang University Bucheon Hospital) ;
  • Kim, Jin-Hwan (Department of Radiology, Chungnam National University School of Medicine) ;
  • Sung, Nak Jin (Department of Family Medicine, Dongguk University College of Medicine) ;
  • Lee, Sang-hyun (Department of Family Medicine, National Health Insurance Service Ilsan Hospital) ;
  • Hwang, Seung-sik (Department of Social and Preventive Medicine, Inha University School of Medicine) ;
  • Kim, Soo Young (Department of Family Medicine, Hallym University College of Medicine) ;
  • Kim, Yeol (National Cancer Control Institute, National Cancer Center) ;
  • Lee, Won-Chul (Department of Preventive Medicine, The Catholic University of Korea College of Medicine) ;
  • Sung, Sook-Whan (Department of Thoracic and Cardiovascular Surgery, The Catholic University of Korea College of Medicine)
  • 장승훈 (한림대학교 의과대학 호흡기-알레르기내과) ;
  • 신승수 (아주대학교 의과대학 호흡기내과) ;
  • 김혜영 (국립암센터 폐암센터 영상의학과) ;
  • 임현우 (가톨릭대학교 의과대학 예방의학교실) ;
  • 박보영 (국립암센터 국제암대학원대학교) ;
  • 김재우 (국립암센터 암검진사업과) ;
  • 박인규 (서울대학교 의과대학 서울대학교병원 흉부외과) ;
  • 김영환 (서울대학교 의과대학 서울대학교병원 호흡기내과) ;
  • 이계영 (건국대학교 의과대학 내과) ;
  • 이경수 (성균관대학교 의과대학 영상의학과, 국립암센터) ;
  • 이종목 (성균관대학교 의과대학, 흉부외과) ;
  • 황보빈 (성균관대학교 의과대학, 호흡기내과) ;
  • 백상현 (순천향대학교 부천병원 영상의학과) ;
  • 김진환 (충남대학교 의과대학 영상의학과) ;
  • 성낙진 (동국대학교 의과대학 가정의학과) ;
  • 이상현 (국민건강보험 일산병원 가정의학과) ;
  • 황승식 (인하대학교 의과대학 예방의학과) ;
  • 김수영 (한림대학교 의과대학 가정의학과) ;
  • 김열 (국립암센터 암검진사업과) ;
  • 이원철 (가톨릭대학교 의과대학 예방의학교실) ;
  • 성숙환 (가톨릭대학교 의과대학 흉부외과)
  • Received : 2015.03.02
  • Accepted : 2015.03.16
  • Published : 2015.04.10

Abstract

Lung cancer is the leading cause of cancer death in many countries, including Korea. The majority of patients are inoperable at the time of diagnosis because symptoms are typically manifested at an advanced stage. A recent large clinical trial demonstrated significant reduction in lung cancer mortality by using low dose computed tomography (LDCT) screening. A Korean multisociety collaborative committee systematically reviewed the evidences regarding the benefits and harms of lung cancer screening, and developed an evidence-based clinical guideline. There is high-level evidence that annual screening with LDCT can reduce lung cancer mortality and all-cause mortality of high-risk individuals. The benefits of LDCT screening are modestly higher than the harms. Annual LDCT screening should be recommended to current smokers and ex-smokers (if less than 15 years have elapsed after smoking cessation) who are aged 55 to 74 years with 30 pack-years or more of smoking-history. LDCT can discover non-calcified lung nodules in 20 to 53% of the screened population, depending on the nodule positivity criteria. Individuals may undergo regular LDCT follow-up or invasive diagnostic procedures that lead to complications. Radiation-associated malignancies associated with repetitive LDCT, as well as overdiagnosis, should be considered the harms of screening. LDCT should be performed in qualified hospitals and interpreted by expert radiologists. Education and actions to stop smoking must be offered to current smokers. Chest radiograph, sputum cytology at regular intervals, and serum tumor markers should not be used as screening methods. These guidelines may be amended based on several large ongoing clinical trial results.

Keywords

References

  1. National Cancer Information Center. Cancer registry statistics 2012 [Internet]. Goyang: National Cancer Information Center: 2012 [cited 2015 Mar 13]. Available from: http://www.cancer.go.kr/mbs/cancer/jsp/album/gallery.jsp?addCancerTitle=읽기(2012년국가암등록통계발표자료)&spage=1&boardId=31817&boardSeq=8471320&mcategoryId=&id=cancer_050207000000.
  2. Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival of Korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat 2013;45:162-171. https://doi.org/10.4143/crt.2013.45.3.162
  3. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. https://doi.org/10.1056/NEJMoa1102873
  4. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-453. https://doi.org/10.1164/rccm.200901-0076OC
  5. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Dossing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thorsen H, Tonnesen P, Pedersen JH. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301. https://doi.org/10.1136/thoraxjnl-2011-200736
  6. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-315. https://doi.org/10.1097/CEJ.0b013e328351e1b6
  7. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, Spaggiari L. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012;157:776-784. https://doi.org/10.7326/0003-4819-157-11-201212040-00005
  8. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429. https://doi.org/10.1001/jama.2012.5521
  9. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening v1. 2014 [Internet]. Washington: National Comprehensive Cancer Network [cited 2015 Mar 13]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf.
  10. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-38. https://doi.org/10.1016/j.jtcvs.2012.05.060
  11. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.
  12. Lee HJ, Kim JH, Kim YK, Park CM, Yi CA, Jeong YJ. Korean Society of thoracic radiology guideline for lung cancer screening with low-dose CT. J Korean Soc Radiol 2012;67:349-365. https://doi.org/10.3348/jksr.2012.67.5.349
  13. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e78S-e92S. https://doi.org/10.1378/chest.12-2350
  14. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
  15. De Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemagi MC, Hazelton WD, Feuer EJ, McMahon PM. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:311-320. https://doi.org/10.7326/M13-2316
  16. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:1865-1873. https://doi.org/10.1001/jama.2011.1591
  17. Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003;58:784-789. https://doi.org/10.1136/thorax.58.9.784
  18. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer 2009;115:5007-5017. https://doi.org/10.1002/cncr.24545
  19. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstralh EJ. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 1991;67(4 Suppl):1155-1164. https://doi.org/10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0
  20. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984;86:44-53. https://doi.org/10.1378/chest.86.1.44
  21. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med 1997;156:320-332. https://doi.org/10.1164/ajrccm.156.1.ats156.1
  22. Ferrigno D, Buccheri G. Clinical applications of serum markers for lung cancer. Respir Med 1995;89:587-597. https://doi.org/10.1016/0954-6111(95)90225-2
  23. Frauenfelder T, Puhan MA, Lazor R, von Garnier C, Bremerich J, Niemann T, Christe A, Montet X, Gautschi O, Weder W, Kohler M; expert panel. Early detection of lung cancer: a statement from an expert panel of the Swiss university hospitals on lung cancer screening. Respiration 2014;87:254-264. https://doi.org/10.1159/000357049
  24. Prokop M. Lung cancer screening: the radiologist's perspective. Semin Respir Crit Care Med 2014;35:91-98. https://doi.org/10.1055/s-0033-1363455
  25. Centers for Disease Control and Prevention. The health consequences of smoking: 50 years of progress [Internet]. Atlanta: Centers for Disease Control and Prevention; 2014 [cited 2015 Mar 13]. Available from: http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/.
  26. Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, Mali W, Thunnissen E, Weenink C, Groen HJ, Lammers JW, Nackaerts K, van Rosmalen J, Oudkerk M, de Koning HJ. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-1667. https://doi.org/10.1183/09031936.00197712
  27. Korean Statistical Information Service. Statistical information service 2014 [Internet]. Daejeon: Statistics Korea; 2014 [cited 2015 Mar 13]. Available from: http://kosis.kr/.
  28. International Agency for Research on Cancer. United States census 2014, expectation of life at birth, 1970 to 2008, and projections, 2010 to 2020 [Internet]. Lyon: International Agency for Research on Cancer; 2014 [cited 2015 Mar 13]. Available from: http://globocan.iarc.fr/.
  29. Park S, Nam BH, Yang HR, Lee JA, Lim H, Han JT, Park IS, Shin HR, Lee JS. Individualized risk prediction model for lung cancer in Korean men. PLoS One 2013;8:e54823. https://doi.org/10.1371/journal.pone.0054823

Cited by

  1. Background and significance of Korean national cancer screening guideline revision vol.58, pp.4, 2015, https://doi.org/10.5124/jkma.2015.58.4.274
  2. Lung Cancer Screening: Update vol.73, pp.3, 2015, https://doi.org/10.3348/jksr.2015.73.3.137
  3. Sociocultural Barriers to Lung Cancer Screening Among Korean Immigrant Men vol.41, pp.4, 2015, https://doi.org/10.1007/s10900-016-0154-1
  4. A Survey of Institutions with Sixteen Detector-Rows or More CT Scanners for the Introduction of National Lung Cancer Screening Program Using Low-Dose Chest CT vol.77, pp.6, 2015, https://doi.org/10.3348/jksr.2017.77.6.404
  5. Evidence of National Lung Cancer Screening Program in Korea vol.19, pp.4, 2015, https://doi.org/10.15384/kjhp.2019.19.4.161
  6. Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors vol.24, pp.1, 2019, https://doi.org/10.15430/jcp.2019.24.1.48
  7. A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea vol.14, pp.7, 2015, https://doi.org/10.1371/journal.pone.0220610
  8. National Lung Cancer Screening in Korea: Introduction and Imaging Quality Control vol.80, pp.5, 2015, https://doi.org/10.3348/jksr.2019.80.5.826
  9. Lung Cancer Screening with Low-Dose CT: Current Status in Other Countries vol.80, pp.5, 2015, https://doi.org/10.3348/jksr.2019.80.5.849
  10. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012 vol.14, pp.10, 2015, https://doi.org/10.1371/journal.pone.0224224
  11. Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program vol.51, pp.4, 2015, https://doi.org/10.4143/crt.2018.464
  12. Korean National Lung Cancer Screening vol.95, pp.2, 2015, https://doi.org/10.3904/kjm.2020.95.2.95